glp 1 agonist drugs mechanism of action of GLP-1 agonists – My Endo Consult Glucagon-like peptide-1 (GLP-1) receptor agonists

Pfizer discussed the case with the study site and internal and external hepatologists, as well as shared clinical details with regulators, including the FDA. The pharma company did not provide any additional details of the discussions with regulators

Problems with cognition and motivation may get in the way of adherence

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al

Efpeglenatide Efpeglenatide is a novel, long-acting GLP-1 receptor agonist developed by Hanmi Pharmaceuticals (South Korea) utilizing the proprietary LAPSCOVERY (Long-Acting Protein/Peptide Discovery) technology platform

[DOI] [PMC free article] [PubMed] 37.Kim YC, Park JH, Prausnitz MR